Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Hair or fiber wrapped tightly around a toe can lead to serious injury if not treated quickly.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Using finasteride with TIP extends time off period for prostate cancer patients.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib might be used to treat hair loss.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

The LTF gene may help predict and manage nonspecific orbital inflammation.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Doctors reported that Follicular Unit Transplantation (FUT) still gives some of the best hair transplant results.

An 11-year-old girl with compulsive hair pulling was successfully treated with therapy and medication.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Oral tofacitinib successfully treated total body hair loss in one patient.

An 11-year-old girl with Trichotillomania developed a large hairball in her stomach, treated with medication, therapy, and family education.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.